U.S. Industrial REITs Stock News

Protagonist Therapeutics: Recent Move After Strong Multi‑Year Returns Protagonist Therapeutics (PTGX) has drawn fresh attention after a strong 1 year total return of about 132%, set against more mixed shorter term moves, including a 7% decline over the past month. See our latest analysis for Protagonist Therapeutics. At a share price of $84.75, Protagonist Therapeutics has seen some momentum cool in the past month. Its 90 day share price return of 9.35% sits against a very large 3 year total...

In January 2026, MyPoint Credit Union announced it had partnered with Upstart to expand access to personal loans via the Upstart Referral Network, giving qualified Upstart.com applicants tailored MyPoint-branded offers and a streamlined digital application and closing process. This partnership, alongside rising attention on Upstart’s upcoming fourth-quarter and full-year 2025 results and ongoing credit-risk concerns, is sharpening focus on how its AI lending model balances growth, funding...

In early January 2026, a Montana federal judge allowed a class-action lawsuit over PFAS-laden firefighter turnout gear against 3M, DuPont/Chemours and others to proceed, rejecting multiple motions to dismiss, including RICO-related challenges. The ruling keeps RICO claims alive pending a Ninth Circuit decision and highlights potentially very large PFAS-related replacement costs for more than one million firefighters’ gear, adding to 3M’s legal and environmental risk profile. We’ll now...

Earlier this month, CVS Health’s board approved a quarterly dividend of US$0.665 per share, payable on February 2, 2026, to shareholders of record as of January 22, 2026, while the company continues to integrate its retail, insurance, and care-delivery operations. Beyond capital returns, CVS Health is reinforcing its healthcare platform credentials through initiatives like expanded specialty programs, new coverage for long-acting injectable HIV prevention, and community investments in...

In January 2026, RWE announced a 50:50 partnership with KKR to develop and operate the Norfolk Vanguard East and West UK offshore wind farms, a roughly 3GW project requiring more than US$15.00 billion in total development and capital expenditure and targeted to supply clean power to over 3 million homes once operational around 2029–2030. This move deepens KKR’s involvement in large-scale renewable infrastructure, linking its capital to the UK’s push to expand offshore wind capacity as a core...

Why STERIS is on investors’ radar today STERIS (STE) has drawn fresh attention after its recent share move, with the stock closing at $268.26 and posting gains over the past week, month, and past 3 months. Investors are reassessing what the current price implies for future returns. See our latest analysis for STERIS. The recent 1-day share price return of 1.52% caps a period of steady gains, with a 30-day share price return of 6.02% and a 1-year total shareholder return of 28.93%. Together,...

In recent months, SMX (Security Matters) has reported expanded real‑world use of its molecular identity platform across metals, textiles, cannabis, electronics, and other regulated supply chains, supported by partnerships such as Dubai Multi Commodities Centre and government-linked A*STAR. An important twist is that this same company, which historically reported zero revenue and relied heavily on capital markets, is now positioning its technology as embedded verification infrastructure that...

Super Group (SGHC) heads into high-profile investor conferences this week as management prepares to address UK gambling duty hikes that could weigh on margins, as well as questions about customer growth and shrinking free cash flow expectations. See our latest analysis for Super Group (SGHC). Despite a 0.81% 1 day share price return to US$10.01, Super Group (SGHC) has seen weaker recent momentum, with a 30 day share price return of 14.30% and a 90 day share price return of 21.98%, in contrast...

Franklin Resources (BEN) is in focus after its Franklin Templeton unit reshaped two institutional money market funds to support tokenized finance uses and blockchain enabled distribution, including a new Digital Institutional Share Class. See our latest analysis for Franklin Resources. Those blockchain focused fund changes arrive during a period of stronger momentum, with a 30 day share price return of 10.65%, a 90 day share price return of 16.56% and a 1 year total shareholder return of...

Recent performance snapshot for Photronics (PLAB) With Photronics (PLAB) shares recently closing at $34.22, investors may be weighing how its recent returns stack up against the company’s fundamentals and what that could mean for their own approach. Over the past week, the stock returned 7.7%, adding to a 1 day move of 8.9%. Over the past month returns were roughly flat, while the past 3 months show a 48.2% gain and the past year a 41.7% total return. Looking further back, Photronics shows a...

Fresh Del Monte Produce Inc. has appointed Mohammed Abbas, 49, as President and Chief Operating Officer, effective January 1, 2026, after previously serving in senior regional and operational roles across Asia Pacific, the Middle East, and North Africa. This promotion of an internally experienced executive into a top leadership role could influence how the company prioritizes regional growth, operational efficiency, and execution on its existing fruit and value-added product strategy. Next,...

If you are wondering whether United Community Banks at US$33.91 is offering good value right now, you are not alone; many investors are asking the same question. The stock has returned 1.9% over the past week, 5.0% over the last month, 7.8% year to date and 9.3% over the past year, with longer term returns of 20.9% over 3 years and 30.1% over 5 years, giving a fuller picture of how it has traded. Recent news flow around United Community Banks has focused on its position within the U.S...

In recent days, SM Energy has drawn heightened attention as analysts updated ratings and earnings expectations following its latest financial results, which included quarterly revenue of US$811.01 million and net profit of US$155.09 million to 30 September. While several firms have trimmed their outlooks and earnings estimates, the stock still carries an overall “Outperform” consensus and is viewed as trading at a discount to peers, highlighting a tension between cautious projections and...

If you are wondering whether Roper Technologies at around US$414 per share still lines up with its underlying worth, this breakdown is designed to help you connect the current price with the fundamentals behind it. The stock has seen a 4.7% decline over the past week, a 6.7% decline over the past month, and it is down 4.7% year to date and 19.7% over the last year, which may have changed how some investors view its potential and risk. Recent news coverage around Roper Technologies has...

If you are wondering whether MercadoLibre's share price around US$2,098.85 still makes sense, or if the market is missing something, this article walks through what the numbers are actually saying about value. The stock has had mixed short term moves, with a 3.7% decline over the last 7 days, an 8.5% gain over 30 days, a 6.3% return year to date, and a 14.2% return over 1 year, while the 3 year return sits at 95.7% and the 5 year return at 8.2%. Recent coverage has focused on MercadoLibre's...

In early January 2026, Bank OZK’s board approved a higher quarterly cash dividend of US$0.46 per common share and declared a US$0.28906 dividend on its 4.625% Series A Non-Cumulative Perpetual Preferred Stock, with both payments scheduled for February record and payment dates that now lie in the past. This marked the sixty-second consecutive quarterly increase in the common dividend, underscoring management’s ongoing emphasis on returning cash to shareholders through regular, incremental...

Alnylam Pharmaceuticals (ALNY) is back in focus after issuing 2026 revenue guidance of US$4.9b to US$5.3b, which it stated implies 71% growth, and outlining long range 2030 goals at the J.P. Morgan Healthcare Conference. See our latest analysis for Alnylam Pharmaceuticals. Despite the upgraded outlook, recent share price performance has cooled, with a 7 day share price return of 10.03% and a 90 day share price decline of 25.40%, even as the 1 year total shareholder return stands at 44.22% and...

Event context and recent share performance Herbalife (HLF) has attracted attention after recent share price moves, with the stock up 5.0% over the past day and 13.7% over the past week, putting its recent momentum in focus for investors. See our latest analysis for Herbalife. That short term strength sits on top of a strong 90 day share price return of 90.19% and a very large 1 year total shareholder return of 156.62%. However, the 5 year total shareholder return is a 67.01% decline, so...

Why GEO Group stock is back in focus GEO Group (GEO) is drawing fresh attention after US Immigration and Customs Enforcement selected the company to operate the planned Big Horn Correctional Facility in Hudson, Colorado under a six month, $39 million sole source contract. See our latest analysis for GEO Group. The contract news has arrived alongside a 9.79% year to date share price return and a 4.48% 7 day share price return, while the 1 year total shareholder return of 48.56% decline...

In its latest quarterly update, Payoneer reported revenues of US$270.9 million, up 9.1% year on year and 2.9% above analyst expectations. The company also marked more than ten consecutive quarters of rising ARPU and SMB take rates as it pushes further into higher-value, multi-product customer relationships. We’ll now explore how this continued ARPU and take rate expansion shapes Payoneer’s existing investment narrative and future earnings assumptions. Rare earth metals are the new gold rush...

SELLAS Life Sciences Group (SLS) is back on investor radars after it agreed with the IMPACT AML network to run a European clinical study of its CDK9 inhibitor, SLS009, in high risk newly diagnosed AML. See our latest analysis for SELLAS Life Sciences Group. The new IMPACT AML agreement comes after a volatile spell where traders focused on financing risk, yet the stock still shows a 74.55% 30 day share price return and a very large 1 year total shareholder return. This suggests momentum has...

IDACORP (IDA) is back on investor radar after a string of recent share price moves, with the stock up over the past week, month, and year despite a weaker past 3 months. See our latest analysis for IDACORP. That recent upswing in IDACORP’s share price, including a 7 day share price return of 4.17% and 30 day share price return of 5.27%, sits alongside a 1 year total shareholder return of 23.98%. This suggests momentum has been building over both shorter and longer horizons. If this kind of...

In early January 2026, CareTrust REIT, Inc. completed a US$142 million acquisition of six Mid-Atlantic skilled nursing facilities under a long-term triple net lease and announced a series of senior promotions and new hires across investments, asset management, legal, analytics, and accounting. This combination of portfolio expansion and reinforced in-house expertise suggests CareTrust is sharpening its focus on scaling healthcare properties while tightening operational oversight. Next, we’ll...

TMC the metals (TMC) is back in focus after news of its formal seabed mining exploration application to U.S. authorities, paired with an upcoming earnings date, has sharpened attention on the stock’s rising speculative options activity. See our latest analysis for TMC the metals. That exploration filing and the upcoming earnings date come after a volatile year, with a 30 day share price return of 7.27% and a 1 year total shareholder return above 300%. Recent speculative options activity hints...